Our pioneering work has resulted in one of the largest bone marrow and stem
cell transplant programs in the world, with unparalleled survival rates.
Associate Professor of Pediatrics and Medicine Medical Director, Pediatric Stem
Cell Transplant Program
A specialist in leukemia, lymphoma, and blood and marrow transplantation, Dr. Collins leads the Hematologic Malignancies / Blood and Marrow Transplantation Program and the combined Adult / Pediatric Stem
Cell Transplant Program at UT Southwestern Medical Center.
Carrie Kitko, M.D., joined the Vanderbilt Pediatric Hematology / Oncology division as the Medical Director of the Pediatric Stem
Cell Transplant Program in June 2015.
The Bone Marrow and Stem
Cell Transplant Program is expanding the use of this technique for patients with solid tumors including neuroblastoma and brain tumors; a variety of high - risk hematologic diseases, such as thalassemia major and transfusion - dependent sickle cell disease; and other nonmalignant diseases.
Robert H. Collins Jr., M.D., FACP, is a Professor of Internal Medicine and Director of both the Hematologic Malignancies / Blood and Marrow Transplantation Program and the Combined Adult / Pediatric Stem
Cell Transplant Program at UT Southwestern Medical Center.
Our stem
cell transplant program laboratory is specially equipped to handle all of the blood and stem cell preparation necessary for transplant, including apheresis (separation and collection of stem cells from the blood) and cryopreservation (freezing of stem cells for future use).
Moffitt has a stem
cell transplant program, and most of the institutions administering CAR T - cell therapy have robust hematopoietic blood stem cell transplant programs because many of the steps involved in CAR T - cell therapy resemble a stem cell transplant, so those pieces are already in place.
Not exact matches
Richard Jones, M.D., professor and director of the Bone Marrow
Transplant Program at Johns Hopkins, developed a now commonly used assay to study ALDH levels in individual
cells.
Rather, the group speculates that the
transplanted cells secreted protective neurotrophins, proteins that promote
cell survival by keeping neurons from inducing apoptosis (
programmed cell death).
«This is such a prevalent virus... about 25 percent of stem
cell transplant patients get infected [with rhinovirus] during the first year,» said Boeckh, who heads Fred Hutch's Infectious Disease Sciences
Program.
«Because of relatively low survival rates and their advancing age, these patients tend to be poor candidates for aggressive therapies, like a bone marrow
transplant,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem
Cell Research
Program at Moores Cancer Center.
«Umbilical cord blood contains an enriched population of bone marrow stem
cells,» says Daniel Weisdorf, director of the Adult Blood and Marrow
Transplant Program at the university.
«Our major CIRM - funded
programs, aimed at engineering young stem
cell - derived astrocytes to secrete GDNF, then
transplanting those
cells back into patients, take on even greater importance, given this aging phenomenon,» said Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine.
«The loss of insulin - producing beta
cells leads to type 1 diabetes, making it an ideal target for
cell replacement therapy,» said James Shapiro, MD, PhD, FRCSC, Director of the Clinical Islet
Transplant Program, University of Alberta.
Through the UCSD Clinical Cardiovascular
Cell Therapy program, Dib and collaborating cardiology faculty plan to conduct clinical studies in a number of areas, including the effectiveness of adult stem cell transplant as a treatment for congestive heart failure; as a way to minimize heart damage after a heart attack; and in the formation of new blood vessels (angiogenesis) to increase blood flow to the heart for patients experiencing chest p
Cell Therapy
program, Dib and collaborating cardiology faculty plan to conduct clinical studies in a number of areas, including the effectiveness of adult stem
cell transplant as a treatment for congestive heart failure; as a way to minimize heart damage after a heart attack; and in the formation of new blood vessels (angiogenesis) to increase blood flow to the heart for patients experiencing chest p
cell transplant as a treatment for congestive heart failure; as a way to minimize heart damage after a heart attack; and in the formation of new blood vessels (angiogenesis) to increase blood flow to the heart for patients experiencing chest pain.
Although cord blood stem
cell transplant is becoming increasingly promising, the Clinical Islet
Program is not currently involved with cord blood as a treatment for diabetes.
$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention
Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem
Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the Lung Cancer Ribbon?
Additionally, she is the Chief Scientific Officer and Medical Director of the Robertson Clinical and Translational
Cell Therapy
Program, Director of the Pediatric Blood and Marrow
Transplant Program, Co-Director of the Stem
Cell Laboratory, as well as Director of the Carolinas Cord Blood Bank.
Jerome Harris Distinguished Professor of Pediatrics & Pathology Chief Scientific Officer and Medical Director, Robertson Clinical & Translational
Cell Therapy
Program Director, Pediatric Blood & Marrow
Transplant Program Director, Carolinas Cord Blood Bank at Duke Durham, NC
At the University of Chicago Medicine, the same team of expert physicians and nurses who provide inpatient blood and bone marrow stem
cell transplant care oversee the outpatient
program.
The
Transplant Optimization Program (TOP) at the University of Chicago Medicine is dedicated to optimizing blood and stem cell transplant for patients at least 50 yea
Transplant Optimization
Program (TOP) at the University of Chicago Medicine is dedicated to optimizing blood and stem
cell transplant for patients at least 50 yea
transplant for patients at least 50 years of age.
It is through this research
program that Penn has made significant advances in improving bone marrow and stem
cell transplants.
Co-Leader, Translational Research and Interventional Oncology Research
Program Professor of Medicine (Hematology / Oncology) Director, Outpatient
Transplant Program Section Chief, Hematology and Stem
Cell Transplant